Aristotle Capital Management LLC trimmed its stake in Dolby Laboratories (NYSE:DLB – Free Report) by 16.1% during the 1st quarter, Holdings Channel reports. The firm owned 208,429 shares of the electronics maker’s stock after selling 39,941 shares during the quarter. Aristotle Capital Management LLC’s holdings in Dolby Laboratories were worth $12,518,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Fifth Third Bancorp lifted its position in Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after purchasing an additional 192 shares during the last quarter. Aquatic Capital Management LLC bought a new position in shares of Dolby Laboratories in the 3rd quarter worth $56,000. iSAM Funds UK Ltd bought a new position in shares of Dolby Laboratories in the 3rd quarter worth $68,000. Allworth Financial LP raised its position in shares of Dolby Laboratories by 99.6% during the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after buying an additional 502 shares in the last quarter. Finally, Quarry LP raised its position in shares of Dolby Laboratories by 1,486.7% during the 4th quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock valued at $76,000 after buying an additional 1,115 shares in the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.
Dolby Laboratories Price Performance
Shares of DLB stock opened at $49.80 on Friday. The stock has a market capitalization of $4.71 billion, a PE ratio of 19.68 and a beta of 0.81. Dolby Laboratories has a 1-year low of $48.26 and a 1-year high of $76.70. The business has a 50-day moving average of $52.36 and a 200 day moving average of $58.96.
Dolby Laboratories Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.9%. Dolby Laboratories’s dividend payout ratio is presently 56.92%.
Insider Activity
In other news, CFO Robert J. Park sold 4,895 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total transaction of $277,448.60. Following the completion of the transaction, the chief financial officer directly owned 81,490 shares of the company’s stock, valued at approximately $4,618,853.20. This represents a 5.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CMO Todd Pendleton sold 11,876 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $54.55, for a total transaction of $647,835.80. Following the sale, the chief marketing officer owned 41,480 shares of the company’s stock, valued at approximately $2,262,734. This represents a 22.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 47,458 shares of company stock worth $2,639,537. 37.93% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
DLB has been the subject of several research reports. Barrington Research reiterated an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a report on Thursday, June 11th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $90.75.
View Our Latest Stock Report on Dolby Laboratories
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
- Five stocks we like better than Dolby Laboratories
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
